市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Nuvalent, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 5.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | 2.0 |
| 技术平均移动指标 | -5.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.00 |
|
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company’s operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 2.83% |
| 机构持股比例 | 108.46% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Paradigm Biocapital Advisors Lp | 30 Sep 2024 | 5,000,000 |
| Perceptive Advisors Llc | 30 Sep 2024 | 2,979,235 |
| Bain Capital Life Sciences Investors, Llc | 30 Sep 2024 | 2,697,267 |
| Fairmount Funds Management Llc | 30 Sep 2024 | 1,687,064 |
| Woodline Partners Lp | 30 Sep 2024 | 1,193,679 |
| Boxer Capital, Llc | 30 Sep 2024 | 1,120,192 |
| Commodore Capital Lp | 30 Sep 2024 | 940,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 134.00 (BMO Capital, 66.87%) | 购买 |
| 中 | 125.00 (55.67%) | |
| 低 | 100.00 (UBS, 24.53%) | 保留 |
| 平均值 | 119.67 (49.03%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 96.30 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BMO Capital | 13 Nov 2024 | 134.00 (66.87%) | 购买 | 90.34 |
| UBS | 24 Oct 2024 | 100.00 (24.53%) | 保留 | 93.63 |
| JP Morgan | 04 Oct 2024 | 125.00 (55.67%) | 购买 | 104.93 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BALCOM ALEXANDRA | - | - | 0 | 0 |
| PELISH HENRY E. | - | - | 0 | 0 |
| PORTER JAMES RICHARD | - | 87.42 | -27,000 | -2,360,340 |
| 累积净数量 | -27,000 | |||
| 累积净值 ($) | -2,360,340 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 87.42 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| PORTER JAMES RICHARD | 职员 | 19 Dec 2024 | 执行期权 | 22,000 | - | - |
| BALCOM ALEXANDRA | 职员 | 17 Dec 2024 | 执行期权 | 13,700 | - | - |
| PORTER JAMES RICHARD | 职员 | 16 Dec 2024 | 自动卖出 (-) | 27,000 | 87.42 | 2,360,340 |
| PORTER JAMES RICHARD | 职员 | 16 Dec 2024 | 执行期权 | 27,000 | - | - |
| PELISH HENRY E. | 职员 | 16 Dec 2024 | 执行期权 | 10,414 | - | - |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合